Who We’ve Worked With
Infinova Biosciences
Infinova is pioneering a neutrophil cell-based drug delivery platform for hard-to-reach solid tumors.
Jabez Biosciences
Jabez is developing a pipeline of – what they are calling – “3-S cancer therapeutics”. These are small molecule therapeutics that are i) Seamless, ii) Scalable, and iii) Synergistic.
Activate Biosciences
Activate Biosciences is pioneering a first-in-class B cell-based vaccine delivery platform for cancer.
Bivium Biosciences
Bivium Biosciences is developing nanobody-based therapeutics for the treatment of neurodegenerative diseases – mainly Multiple Sclerosis and Alzheimer’s Diseases.
Coeptis
Coeptis is building advanced Natural Killer-based cell therapies and synthetic tools to treat a range of diseases, including cancer and autoimmune conditions.
NOK Therapeutics
NOK Therapeutics is developing an autologous, genetically-unmodified Natural Killer (NK) cell therapy for cancer.
Encelta
Encelta is pioneering the first allogeneic T cell therapy that is both safe (does not induce GvHD) but is fully capable of engaging T cell engagers.
Vycellix
Vycellix is developing a suite of complex synthetic tools and cell therapies for various diseases including cancer and autoimmunity.
Fawkes Biotechnology
Fawkes has developed the world’s first blood-based test to detect traumatic brain injury. It’s currently being deployed as a rapid concussion screening tool for use in sports, workplaces, and at home.
About the Founder.
Hi, my name is Jeff Martin. I spent a decade in the lab – countless nights reading, thinking, designing experiments, and coming up with creative solutions to complex problems.
Over time, I came to realize a fundamental flaw in the system: even the best science means nothing if it stays trapped in a lab notebook or buried deep in PubMed. And the people closest to the discoveries – the scientists – are too busy doing the work to tell the story.
For science to make an impact, it needs a translator.
Not a marketer. Not a designer. A scientist that is dedicated to telling the stories that matter.
Jeff Martin, PhD
Founder & Principal
